HOME › DRUGS › ATEZOLIZUMAB
ACTIVE SUBSTANCE / INN

ATEZOLIZUMAB

Brand name(s): Tecentriq, TECENTRIQ
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;…
BLA761034
ACTIVE SUBSTANCE
Atezolizumab
REGULATORS
FDA · EMA
SPONSORS / MAH
Roche Registration GmbH, GENENTECH INC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
TECENTRIQBLA761034GENENTECH INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
TecentriqRoche Registration GmbHAuthorised20/09/2017Carcinoma, Transitional Cell;Carcinoma, Non-Small-Cell Lung;Urologic Neoplasms;B…

FULL INTELLIGENCE ON ATEZOLIZUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →